Olanzapine/Fluoxetine hydrochloride

奥氮平/盐酸氟西汀

Report date: 2026/03/04 15:04:48

Base Information

Drug NameOlanzapine/Fluoxetine hydrochloride
Drug Alias Name奥氮平盐酸氟西汀Olanzapine and Fluoxetine hydrochloride盐酸氟西汀奥氮平Olanzapine/Fluoxetine hydrochlorideFluoxetine hydrochloride and Olanzapine +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D1 receptor antagonistsDopamine D2 receptor antagonistsSerotonin 2 (5-HT2) receptor antagonists +[4] 
TargetsDopamine D1 receptorDopamine D2 receptorSerotonin 2 (5-HT2) receptor +[4] 
Therapy Area/IndicationsBipolar I DisorderDepressive Disorder, Treatment-ResistantDepressive Disorder, Major +[4] 
Global Approved IndicationsBipolar I DisorderBipolar Disorder
Approved Indications in ChinaBipolar I Disorder
Original Approved Country/TerritoryUnited States
Original Approved Date2003/12/24
Country/TerritoryCanadaUnited StatesMainland China
CombinationsYes OlanzapineFluoxetine hydrochloride
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Changtai Pharmaceutical Co Ltd
Inactive CompaniesEli Lilly And Company
Active IndicationsBipolar I Disorder
Inactive IndicationsDepressive Disorder, Treatment-ResistantDepressive Disorder, MajorBipolar Disorder

Other Information

ATC CodeN06CA03
Related LinksWikipediaKEGG